China Water Affairs Group CNY1 billion CGIF-guaranteed bonds offering
The 3.45% bonds are due 2030
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Visen Pharmaceutical HK$783.3 million IPO
The shares are listed on the HKEX
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
MIXUE HK$3.45 billion IPO
We advised MIXUE on its IPO and HKEX listing
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
Laekna HK$236 million placement of shares
We advised Laekna on the placement of new shares
Pony AI $413 million IPO
We advised Pony AI on its IPO, concurrent private placements and Nasdaq listing
Horizon Robotics HK$5.41 billion IPO
We advised Horizon Robotics on its IPO and HKEX listing